Skip to main content

Jean-Marie (John) Canan

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jean-Marie (John) Canan

Jean-Marie (John) Canan is recorded as Board Member at Grace Therapeutics, Inc. (GRCE). Grace Therapeutics, Inc. reported in an 8-K filed March 31, 2023 that Jean-Marie (John) Canan resigned as board of directors, effective March 30, 2023. Grace Therapeutics, Inc. reported in an 8-K filed September 29, 2022 that Jean-Marie (John) Canan was appointed director, effective September 28, 2022.

“On March 30, 2023, Mr. Jean-Marie (John) Canan resigned from the board of directors of Acasti Pharma Inc. (the "Company"), effective immediately.”
Grace Therapeutics, Inc. Form 8-K, filed March 31, 2023 · Read the filing
“Jean Marie (John) Canan, Jan D’Alvise, Donald Olds, Vimal Kavuru and Michael L. Derby were elected as directors of Acasti at the Meeting to serve for a term that expires at the 2023 annual meeting of Acasti shareholders or until their successors are duly elected or appointed, unless such office is earlier vacated in accordance with Acasti’s by-laws.”
Grace Therapeutics, Inc. Form 8-K, filed September 29, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Grace Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.